Publication | Open Access

Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer

Concurrent ChemoradiotherapyDisease ProgressionMedicineCancer ManagementBronchial NeoplasmIntratumoral Metabolic HeterogeneityCancer TreatmentLung CancerOncologyRadiation OncologyTumor MicroenvironmentRadiologyHealth Sciences